Pradžia › Metaboliniai sutrikimai › Texas
Metaboliniai sutrikimai klinikiniai tyrimai Texas
7 tyrimai dėl Metaboliniai sutrikimai ieško dalyvių vietose Texas.
Miestai Texas
Oficialus tyrimo tekstas (anglų kalba)
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- PlanIt Research, LLC (Monitoring Room), Houston
- PlanIt Research, LLC, Houston
- VIP Trials, San Antonio
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT07595549A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Amarillo
- 89bio Clinical Study Site, Austin
- 89bio Clinical Study Site, Austin
- ir dar 30
Renkami dalyviai3 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-03 · NCT06318169A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Amarillo
- 89bio Clinical Study Site, Austin
- 89bio Clinical Study Site, Austin
- ir dar 21
Renkami dalyviai3 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-03 · NCT06419374Genetic and Metabolic Disease in Children
- Children's Medical Center at Dallas, Dallas
Renkami dalyviaiStebimasis tyrimas
1 Day · Visoms lytims · Atnaujinta 2026-07-02 · NCT02650622A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study
- Texas Children's Hospital, Houston
Renkami dalyviai1/2 fazė
Amžius 1 ir vyresni · Visoms lytims · Atnaujinta 2026-03-23 · NCT05130437Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
- Texas Children's Hospital, Houston
Renkami dalyviai1/2 fazė
Visi amžiai · Visoms lytims · Atnaujinta 2026-01-22 · NCT04159103Rare and Atypical Diabetes Network
- Baylor College of Medicine, Houston
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2025-08-14 · NCT05544266Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.